Stay updated on Nivolumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a MedlinePlus Genetics topic covering Multiple myeloma, expanding core content and proper noun coverage.SummaryDifference0.2%

- Check23 days agoChange Detected- Added a government funding notice and current operating status guidance; clarified that the NIH Clinical Center is open; updated the version to v3.2.0. - Removed the older topic reference to MedlinePlus Genetics: Multiple myeloma and old revision tag v3.1.0.SummaryDifference3%

- Check30 days agoChange DetectedUpdate to include MedlinePlus Genetics topic on Multiple myeloma and bump to v3.1.0; remove the older term Plasma cell myeloma and revert to v3.1.0 terminology.SummaryDifference0.4%

- Check37 days agoChange DetectedRemoved MedlinePlus Genetics content related to multiple myeloma, resulting in less genetics-specific information about the disease on the page.SummaryDifference0.2%

- Check44 days agoChange DetectedAdded a MedlinePlus Genetics topic on Multiple myeloma and updated the page to revision v3.0.2; removed the 'Back to Top' element.SummaryDifference0.3%

- Check51 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of multiple myeloma has been removed from the content.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.